Correlation Between Day One and ATyr Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and ATyr Pharma, you can compare the effects of market volatilities on Day One and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and ATyr Pharma.

Diversification Opportunities for Day One and ATyr Pharma

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Day and ATyr is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Day One i.e., Day One and ATyr Pharma go up and down completely randomly.

Pair Corralation between Day One and ATyr Pharma

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.45 times more return on investment than ATyr Pharma. However, Day One Biopharmaceuticals is 2.21 times less risky than ATyr Pharma. It trades about 0.02 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.05 per unit of risk. If you would invest  1,280  in Day One Biopharmaceuticals on August 26, 2024 and sell it today you would earn a total of  92.00  from holding Day One Biopharmaceuticals or generate 7.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy65.17%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  ATyr Pharma

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Day One and ATyr Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and ATyr Pharma

The main advantage of trading using opposite Day One and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.
The idea behind Day One Biopharmaceuticals and ATyr Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes